Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

In vivo single-cell profiling of lncRNAs during Ebola virus infection (Zyagen)

ABSTRACT: In vivo single-cell profiling of lncRNAs during Ebola virus infection (Zyagen)

PROVIDER: PRJNA789769 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR17256200_1.fastq.gz	Fastqsanger.gz
	SRR17256200_2.fastq.gz	Fastqsanger.gz
	SRR17256201_1.fastq.gz	Fastqsanger.gz
	SRR17256201_2.fastq.gz	Fastqsanger.gz
	SRR17256202_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 128

Similar Datasets

In vivo single-cell profiling of lncRNAs during Ebola virus infection.

Project description:In vivo single-cell profiling of lncRNAs during Ebola virus infection.

| PRJNA791539 | ENA

In vivo single-cell profiling of lncRNAs during Ebola virus infection (SABio)

Project description:In vivo single-cell profiling of lncRNAs during Ebola virus infection (SABio)

| PRJNA790971 | ENA

In vivo single-cell profiling of lncRNAs during Ebola virus infection (SABio)

Project description:Long non-coding RNAs (lncRNAs) are pivotal mediators of systemic immune response to viral infection yet most studies concerning their expression and functions upon immune stimulation are limited to in vitro bulk cell populations. This strongly constrains our understanding of how lncRNA expression varies at single-cell resolution, and whether differences with protein coding genes exist in their cell-type specific immune regulatory roles. Here, we perform the first in-depth characterization of lncRNA expression variation at single-cell resolution during Ebola virus (EBOV) infection in vivo. Using bulk RNA-sequencing from 119 samples and 12 tissue types, we significantly expand the current macaque lncRNA annotation. We then profile lncRNA expression variation in immune circulating single-cells during EBOV infection and find that lncRNAs’ expression in fewer cells is a major differentiating factor to their protein coding gene counterparts. Upon EBOV infection, lncRNAs present dynamic and mostly cell-type specific changes in their expression profiles especially in monocytes, the main cell type targeted by EBOV. Such changes are associated with gene regulatory modules related to important innate immune responses such as interferon response and purine metabolism. Within infected cells, several lncRNAs have correlated and anti-correlated expression with viral load, suggesting that expression of some of these lncRNAs might be directly hijacked by EBOV to attack host cells. This study provides novel insights on the roles that lncRNAs play in the host response to acute viral infection and paves the way for future lncRNA studies at single-cell resolution.

2023-04-26 | GSE191315 | GEO

In vivo single-cell profiling of lncRNAs during Ebola virus infection (Zyagen)

2023-04-26 | GSE191102 | GEO

Pre-symptomatic diagnosis of Ebola virus infection

Project description:Normalized Gene expression data used for meta-analysis from studies: GSE31747, GSE8317, GSE24943, GSE24125. We studied the changes in macaque and human peripheral blood cell gene expression after infection with Ebola Zaire virus (EBZ) to identify host responses that occur before the emergence of symptoms. We integrated data from in vivo and in vitro infection studies of macaque or human peripheral blood. We identified mRNAs that were differentially expressed at early, middle, and late times after infection. The EBZ early genes showing increased or decreased expression were then compared to literature-derived host responses to malaria, rhinovirus and influenza virus which identified the patterns unique to each pathogen. From the group of EBZ-specific genes, we next predicted those that encoded secreted or membrane-associated proteins. Pairs of these host response mRNAs or proteins could become candidates for differential diagnosis of an early EBZ infection, before the emergence of conventional symptoms. Four key immune response pathways that were activated early showed profoundly decreased expression at late times.

2016-06-14 | GSE83331 | GEO

Immune parameters and outcome during Ebola virus disease

Project description:Immune patterns in Ebola patients were characterized depending on the outcome of the illness. Non-healthy controls were compared to Ebola patients to define the specificity of the immune response against Ebola virus infection.

2019-05-09 | GSE122692 | GEO

Pre-symptomatic diagnosis of Ebola virus infection

Project description:Pre-symptomatic diagnosis of Ebola virus infection

| PRJNA325626 | ENA

Interferon-γ inhibition of Ebola virus infection

Project description:Interferon-γ inhibition of Ebola virus infection

| PRJNA272680 | ENA

RNAseq analysis of CC F2 female mice at day3 after infection with Ebola virus

Project description:F2 female mice were generated from a cross of two collaborative cross (CC) strains, CC011 x CC074. These mice were infected with Ebola virus and liver samples were prepared at day three after infection. RNA from the livers were prepared and subjected to RNAseq analysis. This data set can be combined with data from GSE165142, in which female mice from the same cross were infected with Ebola virus, and liver samples were prepared at day six after infection. Results: Variations in gene expression levels that may be perdictive for severity

2022-08-31 | GSE173914 | GEO

Ebola virus

Project description:Ebola virus Genome sequencing

| PRJNA360286 | ENA